Companion Diagnostics Market Size, Share | Growth Report 2023-2028
IMARC Group, a leading market research company, has recently releases report titled “Companion Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” The study provides a detailed analysis of the industry, including the global companion diagnostics market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Report Highlights
How big is the companion diagnostics market?
The global companion diagnostics market size reached US$ 5.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 13.3 Billion by 2028, exhibiting a growth rate (CAGR) of 14.4% during 2023-2028.
What is companion diagnostics?
Companion diagnostics are a range of tests that help to match a patient to a particular therapy or drug. These tests are performed through an in-vitro medical device that offers essential information for the safe and effective use of a corresponding drug or biological product. These tests help in diagnosing different categories of diseases, including infectious, neurological, and cardiovascular diseases. Consequently, companion diagnostics are extensively utilized by laboratories, pharmaceuticals, and research institutes.
Request for a free sample copy of this report: https://www.imarcgroup.com/companion-diagnostics-market/requestsample
What are the growth prospects and trends in the companion diagnostics industry?
The rising demand for personalized medicine across the globe is majorly driving the companion diagnostics market growth. The rising awareness regarding the discovery of new biomarkers for diverse medical conditions are further contributing to the market growth. In line with this, an increasing number cases of adverse drug reactions (ADRs) due to the lack of efficacy of treatment methods are fueling the market growth. Furthermore, rising research and development (RD) activities for the development of novel diagnostic tests for chronic diseases are creating a positive outlook for the market.
What is included in market segmentation?
The report has segmented the market into the following categories:
Breakup by Product Service:
- Assays, Kits and Reagents
- Software and Services
Breakup by Technology:
- Immunohistochemistry (IHC)
- Polymerase Chain Reaction (PCR)
- In-situ Hybridization (ISH)
- Real-time PCR (RT-PCR)
- Gene Sequencing
- Others
Breakup by Indication:
- Cancer
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Gastric Cancer
- Melanoma
- Others
- Neurological Diseases
- Infectious Diseases
- Cardiovascular Diseases
- Others
Breakup by End User:
- Pharmaceutical Biopharmaceutical Companies
- Reference Laboratories
- Contract Research Organizations
- Others
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan,India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France,United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Who are the key players operating in the industry?
The report covers the major market players including:
- Abbott Laboratories
- Agilent Technologies
- BioMerieux
- Danaher Corporation
- Roche Holding AG
- Myriad Genetics Inc.
- Siemens Healthcare
- Thermo Fisher Scientific Inc.
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian